DMAC
DiaMedica Therapeutics Inc
NASDAQ: DMAC · HEALTHCARE · BIOTECHNOLOGY
$6.05
+1.51% today
Updated 2026-04-30
Market cap
$341.08M
P/E ratio
—
P/S ratio
66.68x
EPS (TTM)
$-0.70
Dividend yield
—
52W range
$3 – $10
Volume
0.2M
DiaMedica Therapeutics Inc (DMAC) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-67.70%
ROA
-39.90%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2006 | $25737.00 | $-778018.00 | 100.00% | -3,058.67% | -3,022.96% |
| 2007 | $160623.00 | $-2.33M | 100.00% | -1,438.05% | -1,452.78% |
| 2008 | — | $-1.85M | — | — | — |
| 2009 | — | $-2.44M | — | — | — |
| 2010 | $0.00 | $-4.27M | — | — | — |
| 2011 | $0.00 | $-6.61M | — | — | — |
| 2012 | $0.00 | $-10.05M | — | — | — |
| 2013 | $0.00 | $-7.41M | — | — | — |
| 2014 | $0.00 | $-4.82M | — | — | — |
| 2015 | $0.00 | $-1.44M | — | — | — |
| 2016 | $0.00 | $-2.22M | — | — | — |
| 2017 | $0.00 | $-4.26M | — | — | — |
| 2018 | $500000.00 | $-5.73M | 100.00% | -1,352.20% | -1,146.80% |
| 2019 | $0.00 | $-10.65M | — | — | — |
| 2020 | $0.00 | $-12.29M | — | — | — |
| 2021 | $0.00 | $-13.59M | — | — | — |
| 2022 | $0.00 | $-13.68M | — | — | — |
| 2023 | $0.00 | $-19.38M | — | — | — |
| 2024 | $0.00 | $-24.44M | — | — | — |
| 2025 | $0.00 | $-32.77M | — | — | — |